These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2570833)

  • 21. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose and species dependent pharmacokinetics of a novel sigma receptor antagonist, DuP 734.
    Kapil RP; Lam GN
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):3-20. PubMed ID: 7620836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
    Langin D; Paris H; Dauzats M; Lafontan M
    Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.
    Ostenson CG; Pigon J; Doxey JC; Efendic S
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1054-9. PubMed ID: 2903169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs.
    Uemura Y; Tanaka S; Ida S; Yuzuriha T
    J Pharm Pharmacol; 1993 Dec; 45(12):1077-81. PubMed ID: 7908977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idazoxan: a novel xylazine antagonist.
    Doherty T
    Vet Rec; 1985 Aug; 117(6):135. PubMed ID: 2864759
    [No Abstract]   [Full Text] [Related]  

  • 28. Idazoxan and brain alpha 2-adrenoceptors in the rabbit.
    Yakubu MA; Hamilton CA; Howie CA; Reid JL
    Brain Res; 1988 Nov; 463(2):289-95. PubMed ID: 2848612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay.
    Preziosi P; Martire M; Navarra P; Pistritto G; Vacca M
    J Pharmacol Exp Ther; 1989 Apr; 249(1):256-63. PubMed ID: 2565391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
    Valladares JE; Alberola J; Esteban M; Arboix M
    Vet Rec; 1996 Feb; 138(8):181-3. PubMed ID: 8677619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydralazine pharmacokinetics and interaction with food: an evaluation of the dog as an animal model.
    Semple HA; Tam YK; Coutts RT
    Pharm Res; 1990 Mar; 7(3):274-9. PubMed ID: 2339102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of idazoxan on catecholamine systems in rat brain.
    Walter DS; Flockhart IR; Haynes MJ; Howlett DR; Lane AC; Burton R; Johnson J; Dettmar PW
    Biochem Pharmacol; 1984 Aug; 33(16):2553-7. PubMed ID: 6147143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitation of the release of noradrenaline and neuropeptide Y by the alpha 2-adrenoceptor blocking agents idazoxan and hydergine in the dog spleen.
    Schoups AA; Saxena VK; Tombeur K; De Potter WP
    Life Sci; 1988; 42(5):517-23. PubMed ID: 2893235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
    Langin D; Paris H; Lafontan M
    Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells.
    Bidet M; Poujeol P; Parini A
    Biochim Biophys Acta; 1990 May; 1024(1):173-8. PubMed ID: 2337612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
    Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt and (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu administered intravenously to beagle dogs.
    Tokumura T; Machida R; Tsuchiya Y; Sasaki A; Abe K; Tanaka T; Saeki Y
    J Pharm Sci; 1993 Jul; 82(7):725-8. PubMed ID: 8360847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA; Zuidema J
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.